These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6248602

  • 1. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH, The TH.
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [Abstract] [Full Text] [Related]

  • 2. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA.
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [Abstract] [Full Text] [Related]

  • 3. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Oct; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E.
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [Abstract] [Full Text] [Related]

  • 5. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P, Levine PH, Ablashi DV, Royston I.
    Int J Cancer; 1977 Oct 15; 20(4):506-11. PubMed ID: 199544
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G.
    Clin Immunol Immunopathol; 1986 Dec 15; 41(3):342-50. PubMed ID: 3022972
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW, Myrmel H.
    J Clin Virol; 2007 Apr 15; 38(4):292-7. PubMed ID: 17336144
    [Abstract] [Full Text] [Related]

  • 8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M.
    Clin Exp Immunol; 1976 Jul 15; 25(1):1-5. PubMed ID: 186222
    [Abstract] [Full Text] [Related]

  • 9. Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.
    Goldstein K, Lai PK, Lightfoote M, Andrese AP, Fuccillo D, Connor RJ, Levine PH.
    Infect Immun; 1980 Sep 15; 29(3):945-52. PubMed ID: 6253402
    [Abstract] [Full Text] [Related]

  • 10. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffrench R, Khanna R, Lloyd A, Dubbo Infection Outcomes Study.
    J Infect Dis; 2006 Mar 01; 193(5):664-71. PubMed ID: 16453261
    [Abstract] [Full Text] [Related]

  • 11. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 01; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH, Wills A, Reece E, Fox Z.
    Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957
    [Abstract] [Full Text] [Related]

  • 13. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A, Sprössig M, Wutzler P, Färber I, Schweizer H, Swoboda R, Wilke J.
    Laryngol Rhinol Otol (Stuttg); 1983 Apr 15; 62(4):170-4. PubMed ID: 6191167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T, Sullivan JL, Humphreys RE.
    J Infect Dis; 1984 May 15; 149(5):763-8. PubMed ID: 6327851
    [Abstract] [Full Text] [Related]

  • 17. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 18. Studies on the presence of antibodies to EB virus and other herpesviruses in normal children and in infectious mononucleosis.
    Gergely L, Czeglédy J, Váczi L, Szabó B, Binder L, Szalka A.
    Acta Microbiol Acad Sci Hung; 1975 Nov 15; 22(2):75-82. PubMed ID: 164758
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
    Lang D, Vornhagen R, Rothe M, Hinderer W, Sonneborn HH, Plachter B.
    Clin Diagn Lab Immunol; 2001 Jul 15; 8(4):747-56. PubMed ID: 11427421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.